Good
Mostly Aligned
Patient Risk:
Low
Summary
Majority of claims align with the FDA label; several claims are unsupported or only partially supported; two potentially unsafe omissions identified.
Category Scores
Accurate Statements
Fluconazole has good activity mainly against yeasts: Candida species (including most C. albicans infections) and Cryptococcus.
ANTIMICROBIAL ACTIVITY
Fluconazole is not effective against molds like Aspergillus.
ANTIMICROBIAL ACTIVITY
Fluconazole is often very effective for simple vaginal candidiasis.
INDICATIONS AND USAGE; Vaginal candidiasis; DOSAGE AND ADMINISTRATION - Single Dose
Fluconazole is often very effective for simple oral candidiasis.
INDICATIONS AND USAGE; Oropharyngeal candidiasis
Typical single 150 mg dose is used for yeast infections.
DOSAGE AND ADMINISTRATION - Single Dose; Vaginal candidiasis
Many other Candida infections use daily or weekly dosing depending on site and severity.
DOSAGE AND ADMINISTRATION; Systemic Candida infections; Esophageal candidiasis
For serious/systemic infections (e.g., cryptococcal meningitis, esophageal candidiasis), higher or prolonged doses are used and sometimes in combination with other drugs.
Esophageal candidiasis; Systemic Candida infections; Cryptococcal meningitis
Not all Candida species are equally susceptible; C. krusei is often less susceptible.
ANTIMICROBIAL ACTIVITY; Resistance
Some strains of C. glabrata can be harder to treat.
ANTIMICROBIAL ACTIVITY; Resistance
Fluconazole is generally well tolerated.
ADVERSE REACTIONS
Fluconazole can cause liver enzyme changes.
ADVERSE REACTIONS; WARNINGS
Fluconazole can cause rare liver toxicity.
WARNINGS; HEPATO-BILIARY
Fluconazole has interactions with many medicines (warfarin, phenytoin, rifampin, certain other drugs).
Drug Interactions
In pregnancy, avoid high-dose fluconazole unless clearly needed.
WARNINGS; Pregnancy
Unsupported Statements
Fluconazole isn’t 'strong' in a universal sense.
Label does not use subjective descriptors like 'strong' or 'weak'; not a label-supported claim.
Fluconazole is a potent antifungal.
Label describes fluconazole as an antifungal agent but does not use the term 'potent'; not a label-supported phrasing.
Fluconazole can affect heart rhythm in some people.
Label does not explicitly state effect on heart rhythm or QT prolongation.
Use only when benefits outweigh risks.
No blanket risk-benefit gating directive described in the label.
Contradictions
Important Omissions
Heart rhythm/QT-related safety information is not described in the label claims provided.
Importance:
Moderate
No blanket guidance that fluconazole should be used only when benefits outweigh risks (see above omission).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Most claims align with label; two unsupported statements and two omissions present modest safety signaling concerns.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Presence of unsupported claims (heart rhythm, general potency language) and two material omissions.
Suggested Improvement
Limit subjective descriptors; ensure all dosing/spectrum statements are strictly label-supported; explicitly address heart rhythm/QT considerations if applicable; remove blanket 'benefits outweigh risks' language.